Ribopeutic

Ribopeutic was founded in 2022 by world-class experts in RNA structural bioinformatics, RNA molecular and cellular biology, and small molecule drug chemistry targeting RNA. The company has established an AI-powered dry-wet closed-loop target discovery platform, as well as a comprehensive platform for screening, optimizing, and validating small molecules targeting RNA. Ribopeutic has built multiple pipelines for the development of small molecule drugs targeting RNA, covering various therapeutic areas.